TrialFinder ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2017
2017/12
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  11.0% 14.6% 15.3% 16.3% 20.1%  
Credit score (0-100)  24 15 14 11 5  
Credit rating  BB BB BB BB B  
Credit limit (kDKK)  -0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2017
2017/12
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6

Net sales  0 0 0 0 0  
Gross profit  -11.2 -45.9 28.9 -5.5 61.6  
EBITDA  -11.2 -45.9 28.9 -5.5 61.6  
EBIT  -11.2 -45.9 28.9 -5.5 61.6  
Pre-tax profit (PTP)  -14.3 -45.9 28.4 -8.1 61.2  
Net earnings  -14.3 -21.0 17.1 -6.3 47.8  
Pre-tax profit without non-rec. items  -14.3 -45.9 28.4 -8.1 61.2  

 
See the entire income statement

Balance sheet (kDKK) 
2017
2017/12
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  -77.1 30.5 47.5 41.2 89.0  
Interest-bearing liabilities  0.0 19.5 19.5 0.0 0.0  
Balance sheet total (assets)  50.4 55.0 75.8 41.2 104  

Net Debt  -41.0 -10.5 -37.6 -20.2 -96.8  
 
See the entire balance sheet

Volume 
2017
2017/12
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -11.2 -45.9 28.9 -5.5 61.6  
Gross profit growth  76.0% -309.1% 0.0% 0.0% 0.0%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  50 55 76 41 104  
Balance sheet change%  -2.2% 9.1% 37.8% -45.6% 151.8%  
Added value  -11.2 -45.9 28.9 -5.5 61.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -2.0 -3.0 1.0 -1.0 1.0  

Profitability 
2017
2017/12
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -9.3% -50.3% 44.2% -9.4% 84.9%  
ROI %  0.0% -183.9% 49.4% -10.2% 94.6%  
ROE %  -28.1% -51.8% 43.8% -14.3% 73.4%  

Solidity 
2017
2017/12
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
Equity ratio %  -60.5% 55.4% 62.7% 100.0% 85.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  365.4% 22.9% -130.2% 365.6% -157.2%  
Gearing %  0.0% 64.0% 41.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 2.5% 26.8% 0.0%  

Liquidity 
2017
2017/12
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
Quick Ratio  0.4 2.2 2.7 0.0 7.0  
Current Ratio  0.4 2.2 2.7 0.0 7.0  
Cash and cash equivalent  41.0 30.0 57.1 20.2 96.8  

Capital use efficiency 
2017
2017/12
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -77.1 30.5 47.5 41.2 89.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2017
2017/12
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0